Research Topics
| S G GoodmanSummaryAffiliation: St. Michael's Hospital Country: Canada Publications
| Collaborators
|
Detail Information
Publications
PROTECT (Prospective Reinfarction Outcomes in the Thrombolytic Era Cardizem CD Trial): a randomized, double-blind clinical trial of diltiazem versus atenolol in secondary prophylaxis post non-Q wave myocardial infarctionS Goodman
St Michael s Hospital Clinical Trials Unit, University of Toronto, Ontario
Can J Cardiol 12:1183-90. 1996..To describe the rationale and design of the Prospective Reinfarction Outcomes in the Thrombolytic Era Cardizem CD Trial (PROTECT)...
Prevalence of dyslipidemia in statin-treated patients in Canada: results of the DYSlipidemia International Study (DYSIS)Shaun G Goodman
St Michael s Hospital and University of Toronto, Toronto, Ontario
Can J Cardiol 26:e330-5. 2010..Despite clear guideline recommendations, there is a growing body of evidence that there is suboptimal use of lipid-lowering treatment in Canadians...
Enoxaparin and glycoprotein IIb/IIIa inhibition in non-ST-elevation acute coronary syndrome: insights from the INTERACT trialShaun Goodman
St Michael s Hospital, Toronto, Ontario, Canada
Am Heart J 149:S73-80. 2005....
The diagnostic and prognostic impact of the redefinition of acute myocardial infarction: lessons from the Global Registry of Acute Coronary Events (GRACE)Shaun G Goodman
Canadian Heart Research Centre, St Michael s Hospital, University of Toronto, Toronto, Ontario, Canada
Am Heart J 151:654-60. 2006..The impact and prognostic value of the redefinition of myocardial infarction (MI) with more sensitive markers have not been evaluated prospectively in a large, less selected population with acute coronary syndrome (ACS)...
The greatest benefit of enoxaparin over unfractionated heparin in acute coronary syndromes is achieved in patients presenting with ST-segment changes: the Enoxaparin in Non-Q-Wave Coronary Events (ESSENCE) Electrocardiogram Core Laboratory SubstudyShaun G Goodman
Division of Cardiology, Canadian Heart Research Centre, St Michael s Hospital, University of Toronto, Toronto, Ontario, Canada
Am Heart J 151:791-7. 2006....
Acute ST-segment elevation myocardial infarction: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)Shaun G Goodman
St Michael s Hospital, Division of Cardiology, 30 Bond Street, Queen, Toronto, Ontario, Canada
Chest 133:708S-775S. 2008....
The prognostic value of the admission and predischarge electrocardiogram in acute coronary syndromes: the GUSTO-IIb ECG Core Laboratory experienceShaun G Goodman
The Canadian Heart Research Centre, Division of Cardiology, St Michael s Hospital, University of Toronto, Toronto, Canada
Am Heart J 152:277-84. 2006....
The expanded Global Registry of Acute Coronary Events: baseline characteristics, management practices, and hospital outcomes of patients with acute coronary syndromesShaun G Goodman
Canadian Heart Research Centre and Terrence Donnelly Heart Centre, Division of Cardiology, St Michael s Hospital, University of Toronto, 30 Bond St, Room 6 034 Queen, Toronto, Ontario M5B 1W8, Canada
Am Heart J 158:193-201.e1-5. 2009..Expanded GRACE aims to test the feasibility of a simplified data collection tool and provision of quarterly feedback to index individual hospital management practices to an international reference cohort...
Drip-and-ship for acute ST-segment myocardial infarction: the pharmacoinvasive strategy for patients treated with fibrinolytic therapyShaun G Goodman
Terrence Donnelly Heart Centre, Division of Cardiology, St Michael s Hospital, Toronto, Ontario, Canada
Pol Arch Med Wewn 119:726-30. 2009....
Development and prognosis of non-Q-wave myocardial infarction in the thrombolytic eraShaun G Goodman
Division of Cardiology, Canadian Heart Research Center, St Michael s Hospital, Toronto, Ontario, Canada
Am Heart J 144:243-50. 2002..Data on non-Q myocardial infarctions (MI) are derived primarily from prethrombolytic era studies. Previous trials demonstrated different development rates and none reported on clinical outcomes...
Randomized evaluation of the safety and efficacy of enoxaparin versus unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes receiving the glycoprotein IIb/IIIa inhibitor eptifibatideShaun G Goodman
Canadian Heart Research Centre and Terrence Donnelly Heart Centre, Division of Cardiology, St Michael s Hospital, University of Toronto, Toronto, Ontario, Canada
Circulation 107:238-44. 2003..A key issue of uncertainty is the safety and efficacy of combination glycoprotein IIb/IIIa inhibitor and low-molecular-weight heparin therapy...
Low molecular weight heparin decreases rebound ischemia in unstable angina or non-Q-wave myocardial infarction: the Canadian ESSENCE ST segment monitoring substudyS G Goodman
Canadian Heart Research Center, Division of Cardiology, St Michael s Hospital, University of Toronto, Ontario
J Am Coll Cardiol 36:1507-13. 2000..The goal of this study was to determine whether enoxaparin was more effective than heparin in reducing recurrent ischemic episodes...
Non-Q-wave versus Q-wave myocardial infarction after thrombolytic therapy: angiographic and prognostic insights from the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries-I angiographic substudy. GUSTO-I AS G Goodman
The Terrence Donnelly Heart Centre, Division of Cardiology, St Michael s Hospital, University of Toronto, Ontario, Canada
Circulation 97:444-50. 1998....
Randomized trial of low molecular weight heparin (enoxaparin) versus unfractionated heparin for unstable coronary artery disease: one-year results of the ESSENCE Study. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q Wave Coronary EventsS G Goodman
Canadian Heart Research Center, Division of Cardiology, St Michael s Hospital, University of Toronto, Ontario, Canada
J Am Coll Cardiol 36:693-8. 2000....
Temporal trends in the use of invasive cardiac procedures for non-ST segment elevation acute coronary syndromes according to initial risk stratificationS Jedrzkiewicz
Donnelly Heart Centre, Division of Cardiology, St Michael s Hospital, University of Toronto, Toronto, Ontario, USA
Can J Cardiol 25:e370-6. 2009..Although studies in the 1990s suggested that highrisk patients received less aggressive treatment, there are limited data on the contemporary management patterns of NSTE-ACS in Canada...
Prognostic value of dipyridamole SPECT imaging in low-risk patients after myocardial infarctionV Chiamvimonvat
Division of Cardiology, Department of Medicine, Sunnybrook and Women's College Health Sciences Centre, Toronto, Ontario, Canada
J Nucl Cardiol 8:136-43. 2001..The extent of scintigraphic reversibility was directly correlated with clinical events. Therefore scintigraphic imaging remains clinically relevant for risk stratification in the current low-risk population after MI...
Efficacy and safety of the low-molecular weight heparin enoxaparin compared with unfractionated heparin across the acute coronary syndrome spectrum: a meta-analysisSabina A Murphy
TIMI Study Group, Cardiovascular Division, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, 350 Longwood Avenue, First Floor, Boston, MA 02115, USA
Eur Heart J 28:2077-86. 2007....
Relationship of ST elevation in lead aVR with angiographic findings and outcome in non-ST elevation acute coronary syndromesAndrew T Yan
Division of Cardiology, St Michael s Hospital, University of Toronto, and Canadian Heart Research Centre, Toronto, Ontario, Canada
Am Heart J 154:71-8. 2007..Limited data suggest that ST elevation (ST elevation) in aVR is associated with higher mortality and more extensive coronary artery disease in the setting of non-ST elevation acute coronary syndromes (ACS)...
Combining warfarin and antiplatelet therapy after coronary stenting in the Global Registry of Acute Coronary Events: is it safe and effective to use just one antiplatelet agent?Michael C Nguyen
Centre for Cardiovascular Therapeutics, Western Hospital, Melbourne, Australia
Eur Heart J 28:1717-22. 2007..dual antiplatelet therapy plus warfarin leads to an excess of adverse outcomes...
Interactions between heparins, glycoprotein IIb/IIIa antagonists, and coronary intervention. The Global Registry of Acute Coronary Events (GRACE)David Brieger
Concord Hospital, Sydney, Australia
Am Heart J 153:960-9. 2007....
Management patterns in relation to risk stratification among patients with non-ST elevation acute coronary syndromesAndrew T Yan
Division of Cardiology, St Michael s Hospital, University of Toronto, Toronto, Ontario, Canada M5B 1W8
Arch Intern Med 167:1009-16. 2007..We examined the use of in-hospital cardiac catheterization and medications in relation to risk across the broad spectrum of non-ST elevation ACSs...
Treatment and outcomes of patients with evolving myocardial infarction: experiences from the SYNERGY trialChadwick D Miller
Department of Emergency Medicine, Wake Forest University School of Medicine, Winston Salem, NC, USA
Eur Heart J 28:1079-84. 2007..We compared the initial treatment and clinical outcomes of patients presenting with evolving MI (EMI) with those presenting with MI...
Long-term prognostic value and therapeutic implications of continuous ST-segment monitoring in acute coronary syndromeAndrew T Yan
Canadian Heart Research Centre, Division of Cardiology, St Michael s Hospital, University of Toronto, Toronto, Ontario, Canada
Am Heart J 153:500-6. 2007....
Bleeding complications in patients with acute coronary syndrome undergoing early invasive management can be reduced with radial access, smaller sheath sizes, and timely sheath removalWarren J Cantor
Division of Cardiology, St Michael s Hospital, University of Toronto, Toronto, Ontario, Canada
Catheter Cardiovasc Interv 69:73-83. 2007..Our objective was to analyze the impact of arterial access site, sheath size, timing of sheath removal, and use of access site closure devices on high-risk patients with acute coronary syndromes (ACS)...
Comparison of effectiveness of enoxaparin versus unfractionated heparin to reduce silent and clinically apparent acute myocardial infarction in patients presenting with non-ST-segment elevation acute coronary syndromeSanjit Jolly
Terrence Donnelly Heart Centre, Division of Cardiology, St Michael s Hospital, University of Toronto, Toronto, Ontario, Canada
Am J Cardiol 99:186-8. 2007..7% vs 35.9%, p = 0.03). In conclusion, enoxaparin significantly decreased the composite of silent AMI or clinical AMI and death at 1 year (9.3% vs 21%, p = 0.0001)...
Bedtime administration of graded-release diltiazem in patients with inadequate BP control: a tolerability and efficacy studyDavid H Fitchett
Canadian Heart Research Centre, Toronto, Ontario, Canada
Am J Cardiovasc Drugs 6:393-400. 2006..The long duration between administration of the last bedtime dose of antihypertensive medication and the physiologic early morning surge in BP makes it difficult to achieve satisfactory BP control...
Use of proven therapies in non-ST-elevation acute coronary syndromes according to evidence-based risk stratificationGustavo B F Oliveira
Dante Pazzanese Institute of Cardiology, Sao Paulo, Brazil
Am Heart J 153:493-9. 2007..Our objective was to evaluate the relationship between risk stratification and therapeutic decision making in patients with non-ST-segment elevation acute coronary syndromes...
Comparison of utilization of statin therapy at hospital discharge and six-month outcomes in patients with an acute coronary syndrome and serum low-density lipoprotein>or=100 mg/dl versus<100 mg/dlFrederick A Spencer
Department of Medicine, McMaster University, Faculty of Health Sciences, Hamilton, Ontario, Canada, and Coronary Care Unit, Concord Hospital, Sydney, Australia
Am J Cardiol 100:913-8. 2007....
Bleeding and outcome in acute coronary syndrome: insights from continuous electrocardiogram monitoring in the Integrilin and Enoxaparin Randomized Assessment of Acute Coronary Syndrome Treatment (INTERACT) TrialAndrew T Yan
Terrence Donnelly Heart Centre, Division of Cardiology, St Michael s Hospital, University of Toronto, Toronto, Ontario, Canada
Am Heart J 156:769-75. 2008..We sought to determine the relationship between bleeding and myocardial ischemia detected by concurrent continuous electrocardiogram (ECG) monitoring and their independent long-term prognostic significance...
Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-Thrombolysis in Myocardial IStephen D Wiviott
TIMI Study Group, Cardiovascular Division, Department of Medicine, Brigham and Women s Hospital, 75 Francis St, Boston, MA 02115, USA
Circulation 118:1626-36. 2008..We compared prasugrel with clopidogrel among subjects with DM in TRITON-TIMI 38...
Smoking status and antithrombin therapy in patients with non-ST-segment elevation acute coronary syndromeSteve Leung
University of Kentucky, Lexington, KY, USA
Am Heart J 156:177-84. 2008..Smoking remains a major public health issue. We investigated the incidence of smoking and outcomes in high-risk patients with acute coronary syndromes. Differences in treatment effect of antithrombin therapies were also investigated...
Antithrombotic therapy for non-ST-segment elevation acute coronary syndromes: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)Robert A Harrington
Duke Clinical Research Institute, 2400 Pratt Street, Durham, NC 27705, USA
Chest 133:670S-707S. 2008....
Quantitative troponin elevation does not provide incremental prognostic value beyond comprehensive risk stratification in patients with non-ST-segment elevation acute coronary syndromesKi Dong Lim
Terrence Donnelly Heart Centre, Division of Cardiology, St Michael s Hospital, University of Toronto, Toronto, Ontario, Canada
Am Heart J 155:718-24. 2008....
Adverse outcomes in fibrinolytic-based facilitated percutaneous coronary intervention: insights from the ASSENT-4 PCI electrocardiographic substudyMichael A McDonald
Division of Cardiology, University of Alberta, 251 Medical Sciences Building, Edmonton, Alberta, Canada T6G 2H7
Eur Heart J 29:871-9. 2008..Patients in ASSENT-4 PCI undergoing tenecteplase-facilitated percutaneous coronary intervention (PCI) had more adverse events than those undergoing primary PCI. We analysed this to gain further insights...
Prediction of one-year survival in high-risk patients with acute coronary syndromes: results from the SYNERGY trialKenneth W Mahaffey
Duke Clinical Research Institute, Durham, NC 27715, USA
J Gen Intern Med 23:310-6. 2008..Despite advances in pharmacologic therapy and invasive management strategies for patients with non-ST-segment elevation acute coronary syndromes (NSTE ACS), these patients still suffer substantial morbidity and mortality...
Rationale and design of the Trial of Routine ANgioplasty and Stenting After Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction (TRANSFER-AMI)Warren J Cantor
Southlake Regional Health Centre, Newmarket, Ontario, Canada
Am Heart J 155:19-25. 2008..The role of routine early PCI after fibrinolysis, using stents and contemporary pharmacotherapy, has not been studied in a large adequately powered randomized trial...
Optimal medical therapy at discharge in patients with acute coronary syndromes: temporal changes, characteristics, and 1-year outcomeAndrew T Yan
Division of Cardiology, Canadian Heart Research Centre, St Michael s Hospital, University of Toronto, Toronto, Ontario, Canada
Am Heart J 154:1108-15. 2007....
Time to coronary angiography and outcomes among patients with high-risk non ST-segment elevation acute coronary syndromes: results from the SYNERGY trialPierluigi Tricoci
Duke Clinical Research Institute, 2400 Pratt St, Room 0311 Terrace Level, Durham, NC 27705, USA
Circulation 116:2669-77. 2007..We evaluated the relationship between time from hospital admission to coronary angiography and outcomes in high-risk patients with non-ST-segment-elevation acute coronary syndrome who underwent angiography within 48 hours of admission...
Does comorbidity account for the excess mortality in patients with major bleeding in acute myocardial infarction?Frederick A Spencer
Department of Medicine, McMaster University, Faculty of Health Sciences, 1200 Main St W, Hamilton, Canada, L8N 3Z5
Circulation 116:2793-801. 2007..Because these data are not generalizable to all patients with acute myocardial infarction, we sought to better understand the scope of this problem in a "real-world" setting...
Increasing use of single and combination medical therapy in patients hospitalized for acute myocardial infarction in the 21st century: a multinational perspectiveRobert J Goldberg
Division of Cardiovascular Medicine, Department of Medicine, University of Massachusetts Medical School, 55 Lake Ave, Worcester, MA 01655, USA
Arch Intern Med 167:1766-73. 2007..Current practice guidelines recommend the routine use of several effective cardiac medications in hospital survivors of acute myocardial infarction (AMI)...
Paradoxical use of invasive cardiac procedures for patients with non-ST segment elevation myocardial infarction: an international perspective from the CRUSADE Initiative and the Canadian ACS Registries I and IIMohammad I Zia
Canadian Heart Research Centre, Toronto, Canada
Can J Cardiol 23:1073-9. 2007..Practice guidelines support an early invasive strategy in patients with non-ST segment elevation acute coronary syndromes, particularly in those at higher risk...
Transfer for urgent percutaneous coronary intervention early after thrombolysis for ST-elevation myocardial infarction: the TRANSFER-AMI pilot feasibility studyWarren J Cantor
Southlake Regional Health Centre, Newmarket, Canada
Can J Cardiol 22:1121-6. 2006..Urgent PCI after thrombolysis may optimize reperfusion and prevent reinfarction and recurrent ischemia...
Coordinated series of studies to evaluate characteristics and mechanisms of acute coronary syndromes in high-risk patients randomly assigned to enoxaparin or unfractionated heparin: design and rationale of the SYNERGY LibraryJohn L Petersen
Division of Cardiology and Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USA
Am Heart J 148:269-76. 2004..It is hoped that the SYNERGY Library will serve as a model for future substudy design to maximize academic insight within the framework of a large-scale, multicenter trial...
Efficacy and bleeding complications among patients randomized to enoxaparin or unfractionated heparin for antithrombin therapy in non-ST-Segment elevation acute coronary syndromes: a systematic overviewJohn L Petersen
Duke Clinical Research Institute, Durham, NC 27715, USA
JAMA 292:89-96. 2004..CONCLUSION: In a systematic overview of approximately 22 000 patients across the spectrum of ACS, enoxaparin is more effective than unfractionated heparin in preventing the combined end point of death or MI...
Adherence to evidence-based therapies after discharge for acute coronary syndromes: an ongoing prospective, observational studyKim A Eagle
University of Michigan Cardiovascular Center, Ann Arbor, Michigan, USA
Am J Med 117:73-81. 2004..The reasons for noncompliance are complex, and may be elucidated by future studies of medical and social determinants...
Aborted myocardial infarction in patients with ST-segment elevation: insights from the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen-3 Trial Electrocardiographic SubstudyTaha Taher
University of Alberta, Edmonton, Alberta, Canada
J Am Coll Cardiol 44:38-43. 2004..002). CONCLUSIONS: Prompt fibrinolytic treatment improved the likelihood of aborted MI. The subgroup with complete 60-min ST-segment resolution had the best clinical outcomes...
One-year outcome of patients after acute coronary syndromes (from the Canadian Acute Coronary Syndromes Registry)Andrew T Yan
Terrence Donnelly Heart Centre, Division of Cardiology, St. Michael's Hospital, University of Toronto, Ontario, Canada
Am J Cardiol 94:25-9. 2004..Moreover, there was a significant opportunity to enhance the discharge and long-term use of evidence-based secondary prevention therapies...
Low-molecular-weight heparins in ischemic heart diseaseAndrew T Yan
Canadian Heart Research Centre, Toronto, Ontario, Canada
Curr Opin Cardiol 19:309-16. 2004..Ongoing studies will clarify the role of low-molecular-weight heparins as adjunctive therapy for fibrinolysis...
A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registryKim A Eagle
Department of Internal Medicine, University of Michigan Health System, Ann Arbor, USA
JAMA 291:2727-33. 2004..Accurate estimation of risk for untoward outcomes after patients have been hospitalized for an acute coronary syndrome (ACS) may help clinicians guide the type and intensity of therapy...
Elevated leukocyte count and adverse hospital events in patients with acute coronary syndromes: findings from the Global Registry of Acute Coronary Events (GRACE)Mark I Furman
Division of Cardiovascular Medicine, University of Massachusetts Medical School, Worcester, Mass 01655, USA
Am Heart J 147:42-8. 2004..To examine the association between elevated leukocyte count and hospital mortality and heart failure in patients enrolled in the multinational, observational Global Registry of Acute Coronary Events (GRACE)...
Global patterns of use of antithrombotic and antiplatelet therapies in patients with acute coronary syndromes: insights from the Global Registry of Acute Coronary Events (GRACE)Andrzej Budaj
Postgraduate Medical School, Grochowski Hospital Warsaw, Poland
Am Heart J 146:999-1006. 2003..The objective of this report was to describe patterns of use of antithrombotic and antiplatelet therapies in patients with the spectrum of ACS through the use of data from the Global Registry of Acute Coronary Events (GRACE)...
ST segment resolution in ASSENT 3: insights into the role of three different treatment strategies for acute myocardial infarctionPaul W Armstrong
University of Alberta, Edmonton, Canada
Eur Heart J 24:1515-22. 2003..We compared ST resolution in each of the three treatment regimens in order to evaluate the speed, extent and stability of ST segment resolution and its relationship to the primary composite endpoint(s) of the trial...
From guidelines to clinical practice: the impact of hospital and geographical characteristics on temporal trends in the management of acute coronary syndromes. The Global Registry of Acute Coronary Events (GRACE)Keith A A Fox
Department of Cardiology, The Royal Infirmary of Edinburgh, University of Edinburgh, Edinburgh EH3 9YW, Scotland, UK
Eur Heart J 24:1414-24. 2003..The gap between evidence and practice is well recognized but the factors influencing this disjunction, and the extent to which such factors are modifiable, remain uncertain...
Safety and efficacy of unfractionated heparin versus enoxaparin in patients who are obese and patients with severe renal impairment: analysis from the ESSENCE and TIMI 11B studiesSarah A Spinler
Philadelphia College of Pharmacy, University of the Sciences in Philadelphia, PA 19104, USA
Am Heart J 146:33-41. 2003..However, no data are available about the safety and efficacy in patients who are obese and patients with severe renal impairment...
The impact of gender on the treatment and outcomes of patients with early reinfarction after fibrinolysis: insights from ASSENT-2Michael C Tjandrawidjaja
Department of Medicine, Division of Cardiology, 2-51 Medical Sciences Building, University of Alberta, Edmonton, Alberta, Canada
Eur Heart J 24:1024-34. 2003..CONCLUSION: Women with early reinfarction following fibrinolysis for AMI had more frequent early death and were managed less aggressively. These findings suggest the need for increased awareness and timely intervention in these patients...
Clinical trial--derived risk model may not generalize to real-world patients with acute coronary syndromeAndrew T Yan
Terrence Donnelly Heart Centre, Division of Cardiology, St Michael's Hospital, University of Toronto, Toronto, Ontario, Canada
Am Heart J 148:1020-7. 2004..Our findings underscore the potential importance of risk model validation in the general ACS population rather than a clinical trial population to establish its generalizability before integration into clinical practice...
Early cardiac catheterization is associated with lower mortality only among high-risk patients with ST- and non-ST-elevation acute coronary syndromes: observations from the OPUS-TIMI 16 trialWarren J Cantor
Department of Medicine, Division of Cardiology, St Michael s Hospital, University of Toronto, Toronto, Ontario, Canada
Am Heart J 149:275-83. 2005..The benefit of catheterization in both syndromes may depend on patient risk for adverse clinical outcomes...
Underuse of evidence-based treatment partly explains the worse clinical outcome in diabetic patients with acute coronary syndromesRaymond T Yan
Terrence Donnelly Heart Centre, Division of Cardiology, St Michael's Hospital, University of Toronto, Toronto, Ontario, Canada
Am Heart J 152:676-83. 2006..Continued efforts to promote adherence to existing proven therapies and to develop novel treatment strategies targeting diabetes-specific cardiovascular pathophysiology are imperative to improve their adverse prognosis...
Lower is better: implications of the Treating to New Targets (TNT) study for Canadian patientsDavid H Fitchett
Division of Cardiology, St Michael s Hospital, Toronto, Ontario
Can J Cardiol 22:835-9. 2006..Furthermore, registry data show that one-half of these patients are not even achieving the current LDL-C target of 2.5 mmol/L. Causes of the care gap are discussed and possible remedies to achieve the new lower targets are suggested...
Supporting a call to action for peripheral artery disease: insights from two prospective clinical registriesDaniel G Hackam
Canadian Heart Research Center, Toronto, Canada
J Vasc Surg 44:776-81. 2006....
Prognostic significance of admission heart failure in patients with non-ST-elevation acute coronary syndromes (from the Canadian Acute Coronary Syndrome Registries)Amit Segev
The Terrence Donnelly Heart Centre, Division of Cardiology, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada
Am J Cardiol 98:470-3. 2006..In conclusion, in patients with NSTE-ACS, heart failure on admission is associated with increased short- and long-term rates of death and MI...
Age-related differences in the management and outcome of patients with acute coronary syndromesRaymond T Yan
Division of Cardiology, Terrence Donnelly Heart Centre, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada
Am Heart J 151:352-9. 2006..Our findings emphasize the ongoing need to better define and promote optimal therapeutic regimens for elderly patients with ACS...
ST-segment depression in non-ST elevation acute coronary syndromes: quantitative analysis may not provide incremental prognostic value beyond comprehensive risk stratificationAndrew T Yan
Canadian Heart Research Centre, Division of Cardiology, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada
Am Heart J 152:270-6. 2006....
The 12-lead electrocardiogram as a predictive tool of mortality after acute myocardial infarction: current status in an era of revascularization and reperfusionMircea Petrina
University of Michigan Medical Center, Ann Arbor, MI, USA
Am Heart J 152:11-8. 2006..8-4.3). In addition, our review discusses electrocardiographic markers of poor outcome that were not independent risk factors on multivariate analysis, conflicting findings, and knowledge gaps that can help plan future research efforts...
Low-molecular-weight heparin compared with unfractionated heparin for patients with non-ST-segment elevation acute coronary syndromes treated with glycoprotein IIb/IIIa inhibitors: results from the CRUSADE initiativeKanwar P Singh
Division of Cardiology and Duke Clinical Research Institute, Durham, NC 27705, USA
J Thromb Thrombolysis 21:211-20. 2006....
Excess dosing of antithrombotic therapy in non-ST-segment elevation acute coronary syndromesAndrew T Yan
JAMA 295:1896; author reply 1897. 2006
Randomized evaluation of the efficacy of enoxaparin versus unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes receiving the glycoprotein IIb/IIIa inhibitor eptifibatide. Long-term results of the Integrilin David H Fitchett
Canadian Heart Research Centre, St Michael s Hospital, University of Toronto, Toronto, Ontario, Canada
Am Heart J 151:373-9. 2006....
High-risk patients with acute coronary syndromes treated with low-molecular-weight or unfractionated heparin: outcomes at 6 months and 1 year in the SYNERGY trialKenneth W Mahaffey
Duke Clinical Research Institute, Durham, NC 27715, USA
JAMA 294:2594-600. 2005....
Predictors and 1-year outcome of major bleeding in patients with non-ST-elevation acute coronary syndromes: insights from the Canadian Acute Coronary Syndrome RegistriesAmit Segev
Terrence Donnelly Heart Centre, Division of Cardiology, St Michael's Hospital, University of Toronto, Toronto, Ontario, Canada
Am Heart J 150:690-4. 2005..92, 2.07-7.41) and death or MI (2.51, 1.41-4.48). CONCLUSIONS: In patients with NSTE-ACS, major bleeding is associated with increased short- and long-term rates of death and MI, and is predicted by simple clinical characteristics...
Utilization of catheterization and revascularization procedures in patients with non-ST segment elevation acute coronary syndrome over the last decadeGlenn N Levine
Baylor College of Medicine and the Houston VA Medical Center, Houston, Texas 77030, USA
Catheter Cardiovasc Interv 66:149-57. 2005..The percentages of patients undergoing invasive and revascularization procedures were consistently higher in the U.S. cohorts of study subjects when compared to non-U.S. cohorts of study subjects...
Preventing thrombosis: update of first-line therapy in the management of non-ST segment elevation acute coronary syndromesDavid Fitchett
St Michael s Hospital, Toronto, Canada
Can J Cardiol 18:1179-90. 2002..A risk-determined algorithm is presented, which applies observations made at the time of presentation to decide the optimal management for the individual patient...
